文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气消化、代谢与肾脏急症

基于16S rDNA与非靶向代谢组学测序分析脓毒症合并急性呼吸窘迫综合征患者肠道菌群与代谢物的改变

[Alterations in gut microbiota and metabolites of sepsis patients with acute respiratory distress syndrome based on 16S rDNA and untargeted metabolomics sequencing analysis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论脓毒症合并ARDS患者肠道有益菌进一步减少、机会致病菌进一步增多,并影响相关代谢物水平。

该研究纳入2024年1月至5月郑州大学第一附属医院综合ICU收治的脓毒症患者38例,其中合并ARDS者15例,按入院时是否合并ARDS分为ARDS组与非ARDS组。采集诊断脓毒症后24小时内粪便样本行16S rDNA测序及液相色谱-串联质谱非靶向代谢组学分析。结果显示ARDS组SOFA、APACHE II及C反应蛋白水平较非ARDS组显著更高;门水平以变形菌门和拟杆菌门为主,属水平以克雷伯菌属和不动杆菌属为主。LEfSe分析显示ARDS组克雷伯菌属和Anaerofilum丰度显著增加,肠球菌属、链球菌属、Akkermansia和瘤胃球菌属丰度显著降低。代谢组学显示烟酰胺N-氧化物、尿苷、N-乙酰精氨酸等显著上调,赖氨酸、鸟氨酸、N-乙酰天冬氨酸、丙氨酰丙氨酸等显著下调,差异代谢物主要富集于嘧啶代谢、精氨酸和脯氨酸代谢等通路。

要点

  • 脓毒症合并ARDS患者肠道菌群失衡加重:门水平以变形菌门和拟杆菌门为主,非ARDS组以厚壁菌门和疣微菌门为主。
  • 属水平ARDS组以克雷伯菌属和不动杆菌属为主,非ARDS组以肠球菌属、Akkermansia和Ligilactobacillus为主。
  • LEfSe分析显示ARDS组克雷伯菌属和Anaerofilum丰度显著增加,肠球菌属、链球菌属、Akkermansia和瘤胃球菌属丰度显著降低。
  • ARDS组烟酰胺N-氧化物、尿苷、N-乙酰精氨酸等代谢物显著上调,赖氨酸、鸟氨酸、N-乙酰天冬氨酸、丙氨酰丙氨酸显著下调。
  • 联合分析提示克雷伯菌属与烟酰胺N-氧化物、N-乙酰精氨酸正相关,肠球菌属与赖氨酸、鸟氨酸正相关、与烟酰胺N-氧化物负相关。

适用人群与场景

  • 2024年1月至5月郑州大学第一附属医院综合ICU收治的脓毒症患者,按入院时是否合并ARDS分为ARDS组与非ARDS组,最终纳入38例,其中合并ARDS者15例。

研究设计与关键结果

  • 研究类型为16S rDNA测序联合非靶向代谢组学分析,最终纳入脓毒症患者38例,其中合并ARDS者15例。
  • 与非ARDS组比较,ARDS组SOFA、APACHE II及C反应蛋白水平显著更高。
  • 门水平ARDS组以变形菌门和拟杆菌门为主,非ARDS组以厚壁菌门和疣微菌门为主;属水平ARDS组以克雷伯菌属和不动杆菌属为主,非ARDS组以肠球菌属、Akkermansia和Ligilactobacillus为主。
  • LEfSe分析显示,与非ARDS组比较,ARDS组克雷伯菌属和Anaerofilum丰度显著增加,肠球菌属、链球菌属、Akkermansia和瘤胃球菌属丰度显著降低。
  • 非靶向代谢组学显示,与非ARDS组比较,ARDS组烟酰胺N-氧化物、尿苷、N-乙酰精氨酸等代谢物水平显著上调,赖氨酸、鸟氨酸、N-乙酰天冬氨酸、丙氨酰丙氨酸等代谢物水平显著下调。
  • 代谢通路分析显示,与非ARDS组比较,ARDS组差异代谢物主要富集于嘧啶代谢、精氨酸和脯氨酸代谢、赖氨酸生物合成、赖氨酸降解、氨酰-tRNA生物合成、甘氨酸、丝氨酸和苏氨酸代谢。
  • 联合分析提示克雷伯菌属与烟酰胺N-氧化物、N-乙酰精氨酸等代谢物正相关;肠球菌属与赖氨酸、鸟氨酸等代谢物正相关,与烟酰胺N-氧化物负相关。

证据类型、等级与局限

  • 证据类型:基于16S rDNA测序与非靶向代谢组学分析的观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为脓毒症合并ARDS患者肠道有益菌进一步减少、机会致病菌进一步增多,进而影响相关代谢物水平。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the changes of gut microbiota and metabolites between sepsis patients with acute respiratory distress syndrome (ARDS) by using 16S rDNA and untargeted metabolomics sequencing analysis.

METHODS: Patients with sepsis admitted to general intensive care unit (ICU) of the First Affiliated Hospital of Zhengzhou University from January 2024 to May 2024 were enrolled. They were divided into ARDS group and non-ARDS group according to whether ARDS was present at admission. Clinical data were collected, and the fecal samples within 24 hours after diagnosis of sepsis were collected for 16S rDNA sequencing. The denoised sequences amplicon sequence variants were used for diversity analysis, species composition analysis and species difference analysis. The fecal samples were performed for untargeted metabolomics analysis by liquid chromatography-tandem mass spectrometry to screen for differential metabolites and related pathways. Finally, the joint analysis of differential gut microbiota and metabolites was conducted.

RESULTS: Finally, 38 sepsis patients were included, including 15 cases with concomitant ARDS. Compared with the non-ARDS group, the ARDS group had significantly higher sequential organ failure assessment (SOFA), acute physiology and chronic health evaluation II (APACHE II), and C-reactive protein level. The 16S rDNA sequencing results showed that at the phylum level, the ARDS group was mainly composed of Proteobacteria and Bacteroidota, while the non-ARDS group was mainly composed of Firmicutes and Verrucomicrobiota. At the genus level, the ARDS group was mainly composed of Klebsiella and Acinetobacter, while the non-ARDS group was mainly composed of Enterococcus, Akkermansia and Ligilactobacillus. Linear discriminant analysis effect size (LEfSe) showed that compared with the non-ARDS group, the abundance of Klebsiella and Anaerofilum in the ARDS group significantly increased, while the abundance of Enterococcus, Streptococcus, Akkermansia and Ruminococcus in the ARDS group significantly decreased. The untargeted metabolomics analysis showed that compared with the non-ARDS group, the levels of metabolites such as nicotinamide N-oxide, uridine and N-acetyl-arginine were significantly up-regulated in the ARDS group, while the levels of metabolites such as lysine, ornithine, N-acetylaspartic acid and alanylalanine were significantly down-regulated in the ARDS group. The metabolic pathway analysis showed that compared with the non-ARDS group, the differentially expressed metabolites in the ARDS group were mainly enriched in the pyrimidine metabolism, arginine and proline metabolism, lysine biosynthesis, lysinedegradation, aminoacyl-tRNA biosynthesis, glycine, serine and threonine metabolism. The joint analysis indicated that Klebsiella were positively correlated with metabolites such as nicotinamide N-oxide and N-acetyl-arginine. Enterococcus were positively correlated with metabolites such as lysine and ornithine, and negatively correlated with nicotinamide N-oxide.

CONCLUSIONS: The abundance of beneficial bacteria in the gut of sepsis patients with ARDS further decreased, while the abundance of opportunistic pathogens further increased, which in turn affected the levels of related metabolites.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Tong R, Zhang R, Wang M, et al. [Alterations in gut microbiota and metabolites of sepsis patients with acute respiratory distress syndrome based on 16S rDNA and untargeted metabolomics sequencing analysis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41437584. doi:10.3760/cma.j.cn121430-20250513-00463

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。